Programme(s) to which this project applies:
|☒ MPhil/PhD||☑ MRes[Med]||☒ URIS|
Objectives and Significance:
Malignant glioma is the commonest form of primary malignant brain tumours in adults characterised by tumour invasiveness, rapid recurrence, and a poor clinical prognosis. Temozolomide is an effective chemotherapeutic agent, but drug-resistance is common and accounts for the majority of treatment failure. A better understanding of the molecular biology of malignant glioma and of the mechanisms underpinning the development of chemo-resistance is crucial. The present project aims at encouraging and enabling students to identify molecular candidates that can be exploited as potential biomarkers and therapeutic targets. The ultimate goal is to translate laboratory findings into effective treatment.
Research Plan and Methodology:
For more information or to express interest for this project, please email the supervisor or the specified contact point in the project description. Interested candidates are advised to enclose with your email:
Information on the research programme, funding support and admission documentations could be referenced online at the Research Postgraduate Admissions website. General admission enquiries should be directed to email@example.com.
HKUMed MBBS students interested in the Master of Research in Medicine (MRes[Med]) programme may visit the programme website for more information.
HKUMed UG students interested in the Undergraduate Research Internship Scheme (URIS) may visit the scheme’s website for more information.